Cancer stemness in Wnt-driven mammary tumorigenesis

Carcinogenesis

Volumn 35, Issue 1, 2014, Pages 2-13

  Monteiro, Joana ^a   Gaspar, Claudia ^a,d   Richer, Wilfrid ^b   Franken, Patrick F ^a   Sacchetti, Andrea ^a   Joosten, Rosalie ^a   Idali, Anouar ^b   Brandao, Joana ^a   Decraene, Charles ^b,c   Fodde, Riccardo ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b INSTITUT CURIE   (France)

^c CNRS   (France)

^d Instituto Medicina Molecular   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA1 INTEGRIN; CANCER GROWTH FACTOR; CD24 ANTIGEN; MEMBRANE ANTIGEN; PROTEIN P53; SMOOTH MUSCLE ACTIN; SONIC HEDGEHOG PROTEIN; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL LIKE BREAST CANCER; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER PROGNOSIS; CANCER STEM CELL; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL SUBPOPULATION; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; DOWN REGULATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAMMARY STEM CELL; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TRIPLE NEGATIVE BREAST CANCER; WNT SIGNALING PATHWAY;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD24; ANTIGENS, CD29; BREAST NEOPLASMS; CELL DIFFERENTIATION; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASTIC STEM CELLS; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; TRANSCRIPTOME; WNT SIGNALING PATHWAY; WNT1 PROTEIN;

EID: 84891364732     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt279     Document Type: Article

References (50)

1. Visvader,J.E. et al. (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer, 8, 755-768.
2. Reya,T. et al. (2001) Stem cells, cancer, and cancer stem cells. Nature, 414, 105-111.
3. Reya,T. et al. (2005) Wnt signalling in stem cells and cancer. Nature, 434, 843-850.
4. Prosperi,J.R. et al. (2010) A Wnt-ow of opportunity: targeting the Wnt/ beta-catenin pathway in breast cancer. Curr. Drug Targets, 11, 1074-1088.
5. Khramtsov,A.I. et al. (2010) Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am. J. Pathol., 176, 2911-2920.
6. López-Knowles,E. et al. (2010) Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients. Cancer Epidemiol. Biomarkers Prev., 19, 301-309.
7. Perou,C.M. et al. (2000) Molecular portraits of human breast tumours. Nature, 406, 747-752.
8. Gusterson,B.A. et al. (2005) Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer. Breast Cancer Res., 7, 143-148.
9. Gusterson,B. (2009) Do 'basal-like' breast cancers really exist? Nat. Rev. Cancer, 9, 128-134.
10. Hennessy,B.T. et al. (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res., 69, 4116-4124.
11. Lehmann,B.D. et al. (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest., 121, 2750-2767.
12. Liu,C.C. et al. (2010) LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc. Natl Acad. Sci. USA, 107, 5136-5141.
13. Yang,L. et al. (2011) FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene, 30, 4437-4446.
14. Klarmann,G.J. et al. (2008) Epigenetic gene silencing in the Wnt pathway in breast cancer. Epigenetics, 3, 59-63.
15. Suzuki,H. et al. (2008) Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br. J. Cancer, 98, 1147-1156.
16. Nusse,R. et al. (1984) Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature, 307, 131-136.
17. Tsukamoto,A.S. et al. (1988) Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell, 55, 619-625.
18. Michaelson,J.S. et al. (2001) Beta-catenin is a downstream effector of Wntmediated tumorigenesis in the mammary gland. Oncogene, 20, 5093-5099.
19. Imbert,A. et al. (2001) Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J. Cell Biol., 153, 555-568.
20. Kuraguchi,M. et al. (2009) Genetic mechanisms in Apc-mediated mammary tumorigenesis. PLoS Genet., 5, e1000367.
21. Gaspar,C. et al. (2009) A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis. PLoS Genet., 5, e1000547.
22. Hennessy,B.T. et al. (2006) Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann. Oncol., 17, 605-613.
23. Hennessy,B.T. et al. (2005) Squamous cell carcinoma of the breast. J. Clin. Oncol., 23, 7827-7835.
24. Shackleton,M. et al. (2006) Generation of a functional mammary gland from a single stem cell. Nature, 439, 84-88.
25. Zhang,M. et al. (2008) Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res., 68, 4674-4682.
26. Vaillant,F. et al. (2008) The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res., 68, 7711-7717.
27. Cho,R.W. et al. (2008) Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells, 26, 364-371.
28. Edgar,R. et al. (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 30, 207-210.
29. Shipitsin,M. et al. (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell, 11, 259-273.
30. Sleeman,K.E. et al. (2006) CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res., 8, R7.
31. Jolliffe,I.T. (1986) Principal Component Analysis. Springer-Verlag, New York, NY.
32. Barker,N. et al. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature, 449, 1003-1007.
33. Ivshina,A.V. et al. (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res., 66, 10292-10301.
34. Loi,S. et al. (2008) Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics, 9, 239.
35. Miller,L.D. et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl Acad. Sci. USA, 102, 13550-13555.
36. Minn,A.J. et al. (2007) Lung metastasis genes couple breast tumor size and metastatic spread. Proc. Natl Acad. Sci. USA, 104, 6740-6745.
37. Pawitan,Y. et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population- based cohorts. Breast Cancer Res., 7, R953-R964.
38. Sotiriou,C. et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J. Natl Cancer Inst., 98, 262-272.
39. van de Vijver,M.J. et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med., 347, 1999-2009.
40. Takeuchi,T. et al. (2006) Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J. Clin. Oncol., 24, 1679-1688.
41. Leung,S.Y. et al. (2002) Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc. Natl Acad. Sci. USA, 99, 16203-16208.
42. Brabletz,T. et al. (2005) Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat. Rev. Cancer, 5, 744-749.
43. Fodde,R. et al. (2007) Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr. Opin. Cell Biol., 19, 150-158.
44. Visvader,J.E. (2009) Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev., 23, 2563-2577.
45. Stingl,J. et al. (2006) Purification and unique properties of mammary epithelial stem cells. Nature, 439, 993-997.
46. Van Keymeulen,A. et al. (2011) Distinct stem cells contribute to mammary gland development and maintenance. Nature, 479, 189-193.
47. van Amerongen,R. et al. (2012) Developmental stage and time dictate the fate of Wnt/ß-catenin-responsive stem cells in the mammary gland. Cell Stem Cell, 11, 387-400.
48. DiMeo,T.A. et al. (2009) A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelialmesenchymal transition in basal-like breast cancer. Cancer Res., 69, 5364-5373.
49. Lim,E. et al. (2010) Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res., 12, R21.
50. Venet,D. et al. (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput. Biol., 7, e1002240.